HIV VACCINES: Design - Potency - Delivery
Venue: Royal Sonesta Hotel
Location: Cambridge, Massachusetts, United States
Event Date/Time: Jun 22, 2003 | End Date/Time: Jun 23, 2003 |
Description
This conference provides you with state of the art knowledge on designing potent vaccines for the treatment of HIV infection. Leaders from industry and academia will provide you with the latest information on
Increasing the Potency of DNA Vaccines
Gene Shuffling, Expression Vectors and Synthetic Adjuvants
Epidermal Powder Immunization
HIV Gag Vaccines
Multi-Epitope Vaccines
Envelope Molecules Based Vaccines
Peptide Based Vaccines
Synthetic AIDS Vaccines
Gp120-CD4 Receptor Complex
Gaia Cross-Clade HIV Vaccine
Neutralizing Antibodies
Don’t miss this unique opportunity to discuss the latest developments in a forum specifically designed for research on HIV Vaccines. Space is limited, register today.
Pre-Conference Workshop
Immuno Assays:
Overcoming the Challenge of Measuring Immune Responses
Speakers:
M. Caulfield, Merck
D. Chen, PowderJect Vaccines
M. Cho, Case Western Reserve University
A. DeGroot, Epivax
A. DeVico, U. Maryland
M. Egan, Wyeth Research
T. Hanke, MRC, UK
J Joyce, Merck
A. Kalyuzhny, R&D Systems
R. Kowalski, Cylex
J. Lisziewicz, RIGHT
C. Locher, Maxygen
M. Newman, Epimmune
G. Pavlakis, NCI
C. Petropoulos, ViroLogic
P. Poignard, The Scripps Research Institute
E. Rabellino, Beckman Coulter
R. Ruprecht, Dana Farber Cancer Institute
M. Sommerfelt, Bionor Immuno, Norway
J. Ulmer, Chiron
C. Wang, United Biomedical
D. Weiner, U. Pennsylvania School of Medicine